Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003573386 | SCV004353863 | pathogenic | not provided | 2023-06-28 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with EYS-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg232Glufs*25) in the EYS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EYS are known to be pathogenic (PMID: 18836446, 20333770). |
Baylor Genetics | RCV004574084 | SCV005060473 | likely pathogenic | Retinitis pigmentosa 25 | 2024-02-24 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV004818370 | SCV005068737 | pathogenic | Retinal dystrophy | 2022-01-01 | no assertion criteria provided | clinical testing |